Rockefeller Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,120
| Closed | -$850K | – | 1795 |
|
|
2023
Q2 | $850K | Buy |
8,120
+3,978
| +96% | +$417K | ﹤0.01% | 1153 |
|
|
2023
Q1 | $570K | Buy |
4,142
+2,142
| +107% | +$295K | ﹤0.01% | 1300 |
|
|
2022
Q4 | $259K | Sell |
2,000
-5,545
| -73% | -$718K | ﹤0.01% | 1547 |
|
|
2022
Q3 | $834K | Sell |
7,545
-6,910
| -48% | -$764K | ﹤0.01% | 1078 |
|
|
2022
Q2 | $1.08M | Sell |
14,455
-974
| -6% | -$73K | 0.01% | 966 |
|
|
2022
Q1 | $1.21M | Buy |
15,429
+2,062
| +15% | +$161K | 0.01% | 994 |
|
|
2021
Q4 | $1.2M | Buy |
13,367
+4,926
| +58% | +$443K | 0.01% | 987 |
|
|
2021
Q3 | $780K | Buy |
8,441
+6,721
| +391% | +$621K | ﹤0.01% | 1093 |
|
|
2021
Q2 | $133K | Sell |
1,720
-81
| -4% | -$6.26K | ﹤0.01% | 1673 |
|
|
2021
Q1 | $134K | Buy |
1,801
+166
| +10% | +$12.4K | ﹤0.01% | 1484 |
|
|
2020
Q4 | $278K | Sell |
1,635
-8,036
| -83% | -$1.37M | ﹤0.01% | 1087 |
|
|
2020
Q3 | $1.36M | Sell |
9,671
-678
| -7% | -$95.2K | 0.01% | 524 |
|
|
2020
Q2 | $1.66M | Buy |
10,349
+141
| +1% | +$22.6K | 0.02% | 441 |
|
|
2020
Q1 | $998K | Buy |
10,208
+8,385
| +460% | +$820K | 0.01% | 483 |
|
|
2019
Q4 | $235K | Buy |
1,823
+47
| +3% | +$6.06K | ﹤0.01% | 733 |
|
|
2019
Q3 | $134K | Sell |
1,776
-81
| -4% | -$6.11K | ﹤0.01% | 709 |
|
|
2019
Q2 | $282K | Sell |
1,857
-11
| -0.6% | -$1.67K | ﹤0.01% | 525 |
|
|
2019
Q1 | $222K | Buy |
1,868
+11
| +0.6% | +$1.31K | ﹤0.01% | 582 |
|
|
2018
Q4 | $203K | Hold |
1,857
| – | – | ﹤0.01% | 403 |
|
|
2018
Q3 | $300K | Buy |
1,857
+632
| +52% | +$102K | ﹤0.01% | 313 |
|
|
2018
Q2 | $162K | Buy |
+1,225
| New | +$162K | ﹤0.01% | 346 |
|